X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (19724) 19724
Publication (2247) 2247
Newsletter (237) 237
Book Review (234) 234
Book Chapter (118) 118
Conference Proceeding (18) 18
Dissertation (16) 16
Book / eBook (6) 6
Magazine Article (6) 6
Newspaper Article (4) 4
Data Set (3) 3
Reference (3) 3
Presentation (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (9635) 9635
animals (9045) 9045
index medicus (6252) 6252
male (4461) 4461
biochemistry & molecular biology (3336) 3336
female (3200) 3200
mice (2843) 2843
rats (2661) 2661
phospholipases (2647) 2647
phospholipase a (2619) 2619
phospholipases a2 (2200) 2200
cell biology (2073) 2073
signal transduction (1952) 1952
pharmacology & pharmacy (1677) 1677
phospholipase (1619) 1619
phospholipase-c (1529) 1529
activation (1525) 1525
adult (1525) 1525
middle aged (1520) 1520
cells, cultured (1504) 1504
inflammation (1463) 1463
type c phospholipases - metabolism (1406) 1406
proteins (1377) 1377
phospholipases a - metabolism (1372) 1372
immunology (1347) 1347
phosphorylation (1309) 1309
lipids (1241) 1241
research (1221) 1221
calcium - metabolism (1219) 1219
analysis (1203) 1203
expression (1189) 1189
phospholipase a2 (1163) 1163
enzymes (1143) 1143
article (1120) 1120
in vitro techniques (1108) 1108
phospholipase c (1106) 1106
physiological aspects (1075) 1075
aged (1021) 1021
arachidonic acid (1002) 1002
neurosciences (995) 995
kinetics (956) 956
cells (919) 919
research article (913) 913
enzyme inhibitors - pharmacology (911) 911
hematology (901) 901
phospholipases a - blood (876) 876
molecular sequence data (847) 847
physiology (828) 828
protein-kinase-c (821) 821
cell line (819) 819
dose-response relationship, drug (817) 817
amino acid sequence (816) 816
calcium (815) 815
blood platelets - metabolism (814) 814
atherosclerosis (807) 807
time factors (784) 784
enzyme activation (780) 780
biophysics (777) 777
gene expression (741) 741
blood platelets - drug effects (739) 739
toxicology (722) 722
venom (720) 720
rats, sprague-dawley (715) 715
cytosolic phospholipase a (696) 696
signal transduction - drug effects (692) 692
medicine (686) 686
apoptosis (680) 680
risk factors (679) 679
endocrinology & metabolism (672) 672
peripheral vascular disease (659) 659
microbiology (646) 646
phospholipase-d (641) 641
rabbits (639) 639
multidisciplinary sciences (636) 636
health aspects (628) 628
inhibition (624) 624
phospholipases a - antagonists & inhibitors (620) 620
oxidative stress (603) 603
receptor (603) 603
phospholipases - metabolism (600) 600
metabolism (587) 587
mice, inbred c57bl (583) 583
medicine, research & experimental (582) 582
arachidonic acid - metabolism (577) 577
arachidonic-acid (576) 576
hydrolysis (575) 575
phospholipase a 2 (566) 566
signal transduction - physiology (565) 565
blood platelets - enzymology (559) 559
rats, wistar (558) 558
rodents (552) 552
phospholipase d - metabolism (546) 546
phospholipids (541) 541
life sciences (524) 524
platelet aggregation - drug effects (523) 523
genetic aspects (513) 513
identification (507) 507
kinases (503) 503
disease models, animal (499) 499
oncology (498) 498
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (19708) 19708
Japanese (238) 238
Russian (93) 93
French (70) 70
Chinese (51) 51
German (43) 43
Spanish (21) 21
Polish (11) 11
Portuguese (8) 8
Turkish (8) 8
Italian (7) 7
Czech (5) 5
Dutch (2) 2
Ukrainian (2) 2
Greek (1) 1
Hebrew (1) 1
Korean (1) 1
Slovak (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


American Journal of Cardiology, The, ISSN 0002-9149, 2016, Volume 118, Issue 4, pp. 494 - 498
Whether biomarkers associated with cardiovascular disease risk also predict incident diabetes mellitus (DM) is unknown. Our objective was to determine if a... 
Cardiovascular | HEART-DISEASE | CARDIAC & CARDIOVASCULAR SYSTEMS | 21ST-CENTURY | EVENTS | ADIPONECTIN LEVELS | DARAPLADIB | ATORVASTATIN | Osteopontin - blood | Multivariate Analysis | Cystatin C - blood | 1-Alkyl-2-acetylglycerophosphocholine Esterase - blood | CD40 Ligand - blood | Humans | Middle Aged | Male | Secondary Prevention | Insulin - blood | Coronary Artery Disease - blood | Diabetes Mellitus, Type 2 - epidemiology | Incidence | C-Reactive Protein - metabolism | Peptide Fragments - blood | Cardiovascular Diseases - blood | Female | Intercellular Adhesion Molecule-1 - blood | Lipoprotein(a) - blood | Atorvastatin Calcium - therapeutic use | Natriuretic Peptide, Brain - blood | Matrix Metalloproteinase 9 - blood | Receptor for Advanced Glycation End Products - blood | Risk Factors | Biomarkers - blood | Coronary Artery Disease - drug therapy | Neopterin - blood | Chemokine CCL2 - blood | Randomized Controlled Trials as Topic | Vascular Cell Adhesion Molecule-1 - blood | Vitamin D - blood | Adiponectin - blood | Diabetes Mellitus, Type 2 - blood | Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use | Aged | Peroxidase - blood | Medical research | Care and treatment | Calcifediol | Coronary heart disease | Risk factors | Lipoprotein A | Cardiovascular agents | Prevention | Vitamin D | Cardiac patients | Medicine, Experimental | Diabetes | Phospholipases | Alfacalcidol | Blood lipids | Cardiology | Biological markers | Statins | Natriuretic peptides | Plasma | Cardiovascular disease | Lipids | Low density lipoprotein | Cell adhesion & migration
Journal Article
Journal of Thrombosis and Haemostasis, ISSN 1538-7933, 12/2007, Volume 5, Issue 12, pp. 2376 - 2385
Background: Selective inhibitors of cyclooxygenase‐2 (COX‐2) called coxibs, are effective anti‐inflammatory and analgesic drugs. Recently, these drugs were... 
thromboxane | coxibs | thrombin generation | prostacyclin | NSAID | platelet activation | Thrombin generation | Prostacyclin | Platelet activation | Thromboxane | Coxibs | MASS-SPECTROMETRY | CYCLOOXYGENASES | ANTIPLATELET | THROMBOMODULIN | CLOPIDOGREL | PERIPHERAL VASCULAR DISEASE | HEMATOLOGY | EXPRESSION | IONIZATION | TISSUE FACTOR | Humans | Naproxen - pharmacology | Sulfones - adverse effects | Male | Reference Values | Blood Platelets - enzymology | Sulfones - pharmacology | Prostaglandins - blood | Lactones - pharmacology | Phospholipases A - blood | Cyclooxygenase 2 Inhibitors - adverse effects | Sulfonamides - blood | Lactones - blood | Cyclooxygenase 2 - blood | Time Factors | Prostaglandins - urine | Pyrazoles - blood | Antigens, Neoplasm - blood | Adult | Platelet Aggregation - drug effects | Cyclooxygenase 2 Inhibitors - blood | Blood Platelets - drug effects | Sulfones - blood | Pyrazoles - adverse effects | Pyrazoles - pharmacology | Thrombomodulin - blood | Naproxen - adverse effects | Cyclic AMP - blood | Cyclooxygenase 2 Inhibitors - pharmacology | Double-Blind Method | Celecoxib | Lactones - adverse effects | Cell Adhesion - drug effects | Naproxen - blood | Sulfonamides - pharmacology | Thromboxanes - blood | Thromboxanes - urine | Blood Platelets - metabolism | Fibrinogen - metabolism | P-Selectin - blood | Sulfonamides - adverse effects | Leukocytes - drug effects | Platelet Activation - drug effects | Thrombin - metabolism | Platelet Membrane Glycoprotein IIb - blood | Physiological aspects | Prothrombin | COX-2 inhibitors | Thrombin | Analysis
Journal Article
Journal of the American College of Cardiology, ISSN 0735-1097, 2010, Volume 56, Issue 12, pp. 946 - 955
Journal Article
Journal Article
Circulation Research, ISSN 0009-7330, 02/2016, Volume 118, Issue 4, pp. 579 - 585
Journal Article
Journal Article
Journal Article
Atherosclerosis, ISSN 0021-9150, 2016, Volume 253, pp. 156 - 163
Abstract Background and aims Biomarkers and atherosclerosis imaging have been studied individually for association with incident cardiovascular disease (CVD);... 
Cardiovascular | Stroke | High sensitivity troponin T | Carotid intima media thickness | High sensitivity C- reactive protein | Cardiovascular disease | NT-pro B-type natriuretic peptide | Lipoprotein associated phospholipase A2 | lipoprotein(a) | Coronary heart disease | INTIMA-MEDIA THICKNESS | C-REACTIVE PROTEIN | CARDIAC & CARDIOVASCULAR SYSTEMS | RISK PREDICTION | High sensitivity C-reactive protein | B-MODE ULTRASOUND | CYSTATIN C | ALL-CAUSE MORTALITY | MIDDLE-AGED MEN | CARDIAC TROPONIN-T | PERIPHERAL VASCULAR DISEASE | CORONARY-HEART-DISEASE | CAROTID-ARTERY INTIMA | Prospective Studies | Cystatin C - blood | United States | 1-Alkyl-2-acetylglycerophosphocholine Esterase - blood | Albuminuria - blood | Humans | Middle Aged | Male | Incidence | Cardiovascular Diseases - complications | Troponin T - blood | Peptide Fragments - blood | Cardiovascular Diseases - blood | Female | Lipoprotein(a) - blood | C-Reactive Protein - analysis | Natriuretic Peptide, Brain - blood | Biomarkers - metabolism | Carotid Intima-Media Thickness | Atherosclerosis - complications | Biomarkers - blood | Atherosclerosis - blood | Primary Prevention - methods | Cohort Studies | Smoking | Prevention | Medical research | Atherosclerosis | Medicine, Experimental | Biological markers | Epidemiology | Public health | Albumin | Phospholipases | Lipoprotein A | Natriuretic peptides | high sensitivity C-reactive protein | cardiovascular disease | high sensitivity troponin T | coronary heart disease | lipoprotein associated phospholipase A2 | stroke
Journal Article
Diabetes Care, ISSN 0149-5992, 06/2003, Volume 26, Issue 6, pp. 1745 - 1751
Journal Article
Journal Article